Search results for "Infarction"

showing 10 items of 1208 documents

Chapter 15 Pain and itch in Wallenberg's syndrome: anatomical–functional correlations

2006

Publisher Summary The Wallenberg syndrome or dorso-lateral medullary infarction is the most common vascular syndrome of the medulla oblongata. Its clinical features include an ipsilateral Horner's syndrome, an ipsilateral limb ataxia, and mostly an ipsilateral but sometimes also a contralateral or bilateral decrease of pain and temperature sensibility of the face. Patients with Wallenberg's syndrome and with morphological (lesion) or functional (ipsilateral sensory deficit and delayed late blink reflex responses) show evidence of damage to the trigeminal tract and nucleus with sparing of the nucleus caudalis would develop facial pain. The trigeminal trophic syndrome (TTS), a very rare compl…

business.industryLimb ataxiaInfarctionmedicine.diseaseLesionAnesthesiaMedulla oblongatamedicineDementiaTrigeminal trophic syndromeCorneal reflexmedicine.symptombusinessDepression (differential diagnoses)
researchProduct

Letter by Putot et al Regarding Article, “Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction”

2021

business.industryMEDLINEPrognosisBioinformaticsmedicine.diseaseText miningPhysiology (medical)medicineHumansST Elevation Myocardial InfarctionMyocardial infarctionCardiology and Cardiovascular MedicinebusinessAnterior Wall Myocardial InfarctionBiomarkersCirculation
researchProduct

The Yin and Yang of alarmin S100B in the protection of myocardium

2021

business.industryMyocardiumMyocardial InfarctionAlarminsHumansMedicineS100 Calcium Binding Protein beta SubunitGeneral MedicineCardiology and Cardiovascular MedicinebusinessNeuroscienceYin and yangArchives of Cardiovascular Diseases
researchProduct

Abciximab Facilitates the Rate and Extent of Thrombolysis

1999

Background —The TIMI 14 trial tested the hypothesis that abciximab, the Fab fragment of a monoclonal antibody directed to the platelet glycoprotein (GP) IIb/IIIa receptor, is a potent and safe addition to reduced-dose thrombolytic regimens for ST-segment elevation MI. Methods and Results —Patients (n=888) with ST-elevation MI presenting <12 hours from onset of symptoms were treated with aspirin and randomized initially to either 100 mg of accelerated-dose alteplase (control) or abciximab (bolus 0.25 mg/kg and 12-hour infusion of 0.125 μg · kg −1 · min −1 ) alone or in combination with reduced doses of alteplase (20 to 65 mg) or streptokinase (500 000 U to 1.5 MU). Control patients recei…

business.industrymedicine.medical_treatmentStreptokinaseReteplaseThrombolysismedicine.diseaseBolus (medicine)Physiology (medical)AnesthesiamedicineAbciximabPlatelet aggregation inhibitorMyocardial infarctionCardiology and Cardiovascular MedicinebusinessTIMImedicine.drugCirculation
researchProduct

Management and predictors of clinical events in 75 686 patients with acute myocardial infarction

2022

Background:Although mortality of patients with acute myocardial infarction (MI) has decreased substantially over the last few decades in many countries MI remains a major threat to public health. Aims:To assess the number and outcomes of patients hospitalized for acute MI in Poland in 2018 as well as proportions of patients participating in cardiac rehabilitation and undergoing invasive cardiac procedures following discharge. Methods:We used public databases. We included all patients hospitalized for acute MI in Poland in 2018 and assessed event-free survival along with uptake of invasive cardiac procedures and cardiac rehabilitation and consultations with cardiologists. Results: A total of…

cardiac rehabilitationcardiovascular eventsPercutaneous Coronary InterventionTreatment OutcomeMyocardial InfarctionAftercareHumansCoronary Artery BypassCardiology and Cardiovascular Medicinemortalitycoronary artery diseasePatient DischargeAgedKardiologia Polska
researchProduct

In-Hospital and One-Year Outcomes of Patients after Early and Late Resuscitated Cardiac Arrest Complicating Acute Myocardial Infarction—Data fr…

2022

The prognostic role of early (less than 48 h) resuscitated cardiac arrest (ErCA) complicating acute myocardial infarction (AMI) is still controversial. The present study aimed to analyse the short-term and one-year outcomes of patients after ErCA and late resuscitated cardiac arrest (LrCA) compared to patients without cardiac arrest (CA) complicating AMI. Data from the prospective nationwide Polish Registry of Acute Coronary Syndromes (PL-ACS) were used to assess patients with resuscitated cardiac arrest (rCA) after AMI. Baseline clinical characteristics and the predictors of all-cause death were assessed. The all-cause mortality rate, complications, performed procedures, and re-hospitalisa…

cardiac rehabilitationsecondary prevention of sudden cardiac deathdiabetes mellitus; ejection fraction; heart failure; myocardial infarctionlife-threatening ventricular arrhythmiaRMedicineacute coronary syndrome; cardiac rehabilitation; sudden cardiac death; life-threatening ventricular arrhythmia; early and late cardiac arrest; secondary prevention of sudden cardiac deathGeneral Medicineearly and late cardiac arrestsudden cardiac deathacute coronary syndromeJournal of Clinical Medicine; Volume 11; Issue 3; Pages: 609
researchProduct

STEM CELLS FOR TREATMENT OF CARDIOVASCULAR DISEASES: AN UMBRELLA REVIEW OF RANDOMIZED CONTROLLED TRIALS

2021

AIMS:\ud \ud Stem cells are a promising therapy for various medical conditions. The literature regarding their adoption for the clinical care of cardiovascular diseases (CVD) is still conflicting. Therefore, our aim is to assess the strength and credibility of the evidence on clinical outcomes and application of stem cells derived from systematic reviews and meta-analyses of intervention studies in CVD.\ud \ud METHODS and RESULTS:\ud \ud Umbrella review of systematic reviews with meta-analyses of randomized controlled trials (RCTs) using placebo/no intervention as control group. For meta-analyses of RCTs, outcomes with a random-effect p-value< 0.05, the GRADE (Grading of Recommendations Ass…

cardiovascular disease; meta-analysis; randomized controlled trials; stem cells; umbrella review0301 basic medicineUmbrella review.Agingmedicine.medical_specialtyMyocardial InfarctionStem cellsPlaceboBiochemistrylaw.invention03 medical and health sciencesUmbrella review0302 clinical medicineRandomized controlled triallawIntervention (counseling)medicineHumansMeta-analysicardiovascular diseasesMyocardial infarctionIntensive care medicineMolecular BiologyRandomized Controlled Trials as TopicStem cellbusiness.industrymedicine.diseaseCardiovascular diseaseIntervention studiesMeta-analysisCardiovascular diseases030104 developmental biologySystematic reviewAN UMBRELLA REVIEW OF RANDOMIZED CONTROLLED TRIALS.- Ageing research reviews ss.101257 2021 [Demurtas J. Fanelli G. N. Romano S. L. Solari M. Yang L. Soysal P. Sánchez G. F. L. Grabovac I. Smith L. Zorzi A. et al. -STEM CELLS FOR TREATMENT OF CARDIOVASCULAR DISEASES]NeurologyCardiovascular DiseasesRandomized controlled trialMeta-analysisCardiovascular disease; Meta-analysis; Randomized controlled trials; Stem cells; Umbrella review; Humans; Randomized Controlled Trials as Topic; Stem Cells; Cardiovascular Diseases; Myocardial InfarctionRandomized controlled trialsCardiovascular disease; Stem cells; Umbrella review; Meta-analysis; Randomized controlled trialsStem cellbusiness030217 neurology & neurosurgeryBiotechnology
researchProduct

Obstrucción microvascular derivada de la resonancia margnética cardiaca tras un infarto miocárdico con elevación del ST –asociación con marcadores de…

2013

Este trabajo, que se dividió en tres partes, pretendió determinar la asociación entre la obstrucción microvascular (MVO) estimada mediante resonancia magnética cardiaca (RMC) con determinados marcadores ampliamente disponibles en el contexto del infarto agudo de miocardio con elevación del segmento-ST (IAMCEST). La RMC permite una exhaustiva evaluación de los pacientes con IAMCEST. En este sentido, la aparición de MVO ha mostrado ser un factor asociado a episodios cardiovasculares adversos mayores y remodelado negativo tras un IAMCEST. En la primera parte de este trabajo, pretendimos explorar la asociación entre el sumatorio de las derivaciones con ST elevado (sum-ST) y la resolución del se…

cardiovascular magnetic resonanceST elevation myocardial infarctioncardiologymicrovascular obstruction
researchProduct

Myocardial infarction in Young adults: risk factors, clinical characteristics and prognosis according to our experience

2013

Objectives. Myocardial infarction is a relatively unusual phenomenon in young subjects. The aim if this work is to characterize the risk profile and factors influencing outcomes of these patients since it makes possible to manage prevention interventions. Patients and Methods. We examined cardiovascular risk factors, clinical presentation, angiographic picture and outcome of a group of young patients hospitalized for a myocardial infarction. We enrolled 121 young patients consecutively admitted to our hospital for a myocardial infarction and examined them not only at the initial stage, but also after 3 months and one year; finally a long-term telephonic follow up was performed, when possibl…

cardiovascular prevention cardiovascular risk factors coronary artery disease ischemic heart disease myocardial infarction young adults
researchProduct

Role of genetic polymorphisms in myocardial infarction at young age

2010

Acute myocardial infarction (AMI) in young adult presents a typical pattern of risk factors, clinical, angiographic and prognostic characteristics. In the last years we demonstrated that hemorheological profile is altered in these patients in a persistent way and independently of the number of risk factors and of the extent of coronary lesions. Thus, the hyperviscosity syndrome following AMI could be considered an intrinsic characteristic of these patients. Consequently it is possible to hypothesise the presence of a genetic background at the origin of this predisposition. If this background is able to influence the risk of ischemic heart disease, this should be particularly evident in youn…

cardiovascular risk factorsAdultMalePathologymedicine.medical_specialtyPhysiologyPopulationMyocardial InfarctionCoronary DiseaseSingle-nucleotide polymorphismDiseaseBiologyPolymorphism Single NucleotideConnexinsPhysiology (medical)Genetic predispositionmedicineHumansSNPGenetic Predisposition to DiseaseMyocardial infarctionAlleleeducationAged 80 and overInflammationeducation.field_of_studyHaplotypeHematologyMiddle AgedPyrinmedicine.diseaseInterleukin-10Platelet Endothelial Cell Adhesion Molecule-1Toll-Like Receptor 4Juvenile myocardial infarctiongenetic patternCytoskeletal ProteinsC-Reactive ProteinImmunologyFemaleCardiology and Cardiovascular MedicineClinical Hemorheology and Microcirculation
researchProduct